From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?
Katie Dickson, Daniel Stubbings, Megan Hurst, Joseph L. Davies
Journal of Psychoactive Drugs September 11, 2025 DOI: 10.1080/02791072.2025.2558579 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 250 |
| Population | UK adults aged 18–86 |
| Keywords | Openness to experience Legalization Perception Framing construction Politics Public policy Public health Public opinion Suicide prevention Criminology Drug Criminal justice Odds |
| Citations | 2 |
| Key findings | Viewing drug use as a health issue rather than a criminal issue predicted support for psychedelic legalization and lower perceived risk. |
Abstract
Psychedelic substances have gained attention for their therapeutic potential, yet they remain illegal in the UK. This study aimed to explore whether public attitudes toward UK drug policy predicted attitudes toward psychedelics, in terms of their legal status, the effects of psychedelics on individuals and society, the risks associated with psychedelic use, and personal openness toward psychedelic experiences and their potential positive effects. A cross-sectional survey was conducted with 250 participants aged 18–86 (M = 38.1, SD = 15.8), using the APQ and sociodemographic measures. Multiple regression analyses revealed that viewing drug use as a health issue, rather than a criminal issue, was a significant predictor of support for psychedelic legalization and lower perceived risk. Additionally, gender, religious affiliation, political leaning, and prior drug use significantly influenced attitudes toward psychedelics. Women and religious individuals tended to view psychedelics as more harmful, while left-leaning and non-religious participants were more supportive of their therapeutic use. Participants with prior drug use experience were more open to psychedelics. These findings suggest that public attitudes may be influenced by broader drug policy perceptions and that shifts in policy framing toward health-based approaches could foster greater support for psychedelic reform. Further research should explore these associations longitudinally.
Citations in the library
Cited by 2
Cites 36
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Journal of Psychopharmacology November 11, 2014
and 31 more in the library